Drug-induced liver injury secondary to androgenic steroid use
DOI:
https://doi.org/10.47993/gmb.v47i1.800Keywords:
hepatitis, anabolic steroids, hepatotoxicity, DILIAbstract
The use of anabolic steroids in an illicit way is a growing problem characterized by the lack of knowledge about the potential side effects of these products. The illegal use of these products has led to an underdiagnosis of adverse events, among the most frequent being hepatotoxicity. We present the case of a mature adult male amateur athlete who was hospitalized for jaundice and drug-induced liver disease related to the use of high-dose anabolic steroids.
Prevention of drug-induced liver injury (DILI) involves educating patients taking hepatotoxic drugs about their safe use, teaching the signs and symptoms associated with liver injury, as well as educating the vulnerable population in preventing self-medication or illegal use of these substances.
Metrics
References
Rodríguez Alfaro, J. M., Álvarez Castillo, A., & Salas Boza, A. (2020). Esteroides anabólicos: repercusiones médicas del uso indiscriminado con fines en la mejora del rendimiento atlético. Revista Medica Sinergia, 5(7), e531. https://doi.org/10.31434/rms.v5i7.531 DOI: https://doi.org/10.31434/rms.v5i7.531
García F. Implicaciones andrológicas del abuso de esteroides androgénicos anabolizantes. Rev Int Androl. 2011;9(4):160-169. DOI: https://doi.org/10.1016/S1698-031X(11)70034-6
AlShareef S, Gokarakonda SB, Marwaha R. Anabolic Steroid Use Disorder (https://www.ncbi.nlm.nih.gov/books/NBK538174/). [Updated 2022 Jun 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
Garcia-Cortes M, Robles-Diaz M, Stephens C, et al. Drug induced liver injury: an update. Arch Toxicol 2020; 94:3381. DOI: https://doi.org/10.1007/s00204-020-02885-1
Vuppalanchi R, Liangpunsakul S, Chalasani N. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States? Am J Gastroenterol 2007; 102:558. DOI: https://doi.org/10.1111/j.1572-0241.2006.01019.x
Lagos-Ortiz RA, Espinoza-Flores ST, Barriga-Arriagada SE, Cifuentes-Villena I, Sobarzo A, Morales Ojeda I. Caracterización y riesgos respecto al uso ilegal de esteroides anabólicos androgénicos en deportistas. ODEP [Internet]. 20 de enero de 2022 [citado 18 de diciembre de 2023];:11-2
Pontet Yéssica, Calleri Alfonso, Hernández Nelia. Hepatotoxicidad por esteroides anabólicos androgénicos, reporte de 2 casos en Uruguay. Anfamed [Internet]. 2018 Dic [citado 2023 Dic 17] ; 5( 2 ): 116-122. DOI: https://doi.org/10.25184/anfamed2018v5n2a4
Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to druginduced liver injuries. J Clin Epidemiol 1993; 46: 1323-1330 DOI: https://doi.org/10.1016/0895-4356(93)90101-6
Chalasani NP, Maddur H, Russo MW, et al. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol 2021; 116:878. DOI: https://doi.org/10.14309/ajg.0000000000001259
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Gaceta Médica Boliviana
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
